Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Code | Size | Price |
---|
RPH323Hu02-10ug | 10ug | £132.00 |
Quantity:
RPH323Hu02-50ug | 50ug | £285.00 |
Quantity:
RPH323Hu02-100ug | 100ug | £439.00 |
Quantity:
RPH323Hu02-200ug | 200ug | £540.00 |
Quantity:
RPH323Hu02-1mg | 1mg | £1,560.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunoprecipitation (IP)
- SDS-PAGE
- Western Blot (WB)
Documents
Further Information
Accurate Molecular Mass(KD):
40kDa
Alternative Names:
MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors
Buffer Formulation:
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Endotoxin Level:
<1.0EU per 1ug (determined by the LAL method)
Expression System:
Prokaryotic expression
Fragment:
Asn416~Leu502
Isoelectric Point:
6.2
Item Name:
Preferentially Expressed Antigen In Melanoma
Organism Species:
Homo sapiens (Human)
Predicted Molecular Mass(KD):
39.9kDa
Purity:
> 90%
Source:
Prokaryotic expression
Subcellular Location:
Membrane, Nucleus
Tag:
N-terminal His and GST Tag
Traits:
Freeze-dried powder
Uniprot ID:
P78395